APTAHEM
Aptahem's development portfolio consists of aptamers , so-called synthetic (engineered) nucleic acid polymers. An aptamer consists of either single-stranded DNA or RNA (ssDNA or ssRNA). These molecules can bind specifically to already selected targets, including proteins and peptides with high affinity and specificity. Unlike antibodies, some aptamers exhibit stereoselectivity. Aptahem develops aptamer-based drugs for the treatment of life-threatening conditions where coagulation and inflammation interact in the disease process. Apta-1, the company's leading drug candidate, is an emergency medicine that is developed with the aim of stopping the organ and tissue damage that leads to the very high mortality rate for, among other things, sepsis patients.
APTAHEM
Industry:
Biotechnology
Founded:
2014-01-01
Address:
Malmö, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.aptahem.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Euro Danish Server Location
Similar Organizations
Aptarion biotech
Aptarion biotech is a developer Biostable L-Aptamers for the treatment Of Life-Threatening diseases And for Biosensors.
F2G
F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.
Vetigenics
Vetigenics discovers and develops antibody-based immunotherapies to treat cancer and chronic diseases in companion animals
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-31 | Aptahem appoints CMC Director |
Official Site Inspections
http://www.aptahem.com Semrush global rank: 11.53 M Semrush visits lastest month: 156
- Host name: webcluster2.webpod16-cph3.one.com
- IP address: 46.30.215.119
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "Aptahem"
Aptahem - Crunchbase Company Profile & Funding
Aptahem develops aptamer-based drugs for the treatment of life-threatening conditions where coagulation and inflammation interact in the disease …See details»
About Aptahem
Aptahem will deliver best in class RNA-based drugs for sepsis and other severe inflammatory conditions, thereby saving patients’ lives and improving treatment options. Mission Aptahem …See details»
Aptahem
AptahemSee details»
Aptahem: Contact Details and Business Profile - RocketReach
Aptahem AB is a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of life-threatening conditions in which a combination of coagulation and inflammation …See details»
Aptahem AB Company Description - Stock Analysis
Nov 4, 2024 Aptahem AB (publ), a clinical stage biotechnology company, develops aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions. Its principal …See details»
Aptahem AB (publ) (APTA.ST) - Yahoo Finance Canada
See the company profile for Aptahem AB (publ) (APTA.ST) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Aptahem - LinkedIn
Aptahem AB is a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of life-threatening conditions in which a combination of coagulation and inflammation …See details»
Aptahem - Products, Competitors, Financials, Employees, …
Aptahem enters strategic collaboration agreement with e-Projection to more efficiently achieve partnership in Japan. Oct 22, 2024. Aptahem enters strategic collaboration agreement with e …See details»
Aptahem - Overview, News & Similar companies | ZoomInfo.com
Mar 27, 2024 Who is Aptahem. Aptahem AB (APTA) is a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of life-threatening conditions in which a …See details»
Aptahem - VentureRadar
Aptahem AB is a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of life-threatening conditions in which a combination of coagulation and inflammation …See details»
Aptahem Company Profile - Office Locations, Competitors ... - Craft
Aptahem is a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of life-threatening conditions. It provides Apta-1, a pharmaceutical candidate that …See details»
Aptahem - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Aptahem . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. About. Aptahem has 4 current …See details»
Investor Relations - Aptahem
Aptahem’s aim is to enter into such an agreement for the drug candidate Apta-1 in early clinical phase. Apta-1 as a new potential treatment for sepsis. Sepsis is a global, challenging and …See details»
Aptahem Company Profile 2024: Stock Performance & Earnings
Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main …See details»
Aptahem - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 Organization. Aptahem . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 12. Monthly Visits 548. …See details»
Aptahem » Annual Report 2022
News Aptahem beslutar om en partiellt garanterad företrädesemission av aktier om cirka 22,7 MSEK och upptar brygglån 10 Oct, 2024. About Aptahem. Business Strategy; Business …See details»
Several ownership changes in Aptahem after completed rights issue
Dec 5, 2024 The research company Aptahem has carried out a rights issue, which means that several shareholders have crossed flagging limits. This is stated in a press release. Tuvedalen …See details»
Aptahem » Annual Report 2021
We kindly decline all direct contact with salespersons of different types of products and services.See details»
Aptahem » RNA-therapeutics
Dec 10, 2024 Aptahem’s development portfolio comprises RNA-based aptamers, so-called synthetic (artificial) nucleic acid polymers. An aptamer consists either of single-stranded DNA …See details»